Last edition
News about "CRDMO"
WuXi Biologics Completes First Commercial PPQ Campaign at MFG20 Hangzhou Facility
WuXi Biologics completes the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000L single-use bioreactors (SUBs).
CRDMO | 19/04/2025 | By Abha
Sai Life Sciences Establishes Peptide Research Centre in Hyderabad
Sai Life Sciences has inaugurated a state-of-the-art Peptide Research Centre at its Hyderabad R&D campus, expanding its capabilities in complex peptide synthesis and conjugation to support next-generation therapeutics.
CRDMO | 04/04/2025 | By Abha
Ribobay Pharma Offers oligo CRDMO Services with Cytiva FlexFactory Platform
Ribobay Pharma has announced that it will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
CRDMO | 13/05/2024 | By Aishwarya | 140
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services
WuXi Biologics, Boostimmune Ink MOU for Exclusive R&D Services<br />
CRDMO | 24/08/2023 | By Sudeep Soparkar | 480
GeneFab to Sublease Senti Biosciences cGMP Facility
GeneFab to Sublease Senti Biosciences cGMP Facility<br />
CRDMO | 18/08/2023 | By Sudeep Soparkar | 292
WuXi STA adds peptide manufacturing capacity at Changzhou campus
With two new 2,000L reactors the total reactor volume of the Solid Phase Peptide Synthesizers at WuXi TIDES has increased to over 10,000 litres
CRDMO | 08/05/2023 | By Sudeep Soparkar | 518
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy